0 CHECKOUT

Hemorrhage - Pipeline Review, H1 2015

  • ID: 3129746
  • February 2015
  • 41 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Cellphire, Inc.
  • Digna Biotech, S.L.
  • Haemostatix Ltd
  • QRxPharma Limited
  • MORE

Hemorrhage - Pipeline Review, H1 2015

Summary

This ‘Hemorrhage - Pipeline Review, H1 2015’, provides an overview of the Hemorrhage’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hemorrhage, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemorrhage and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by this team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cellphire, Inc.
  • Digna Biotech, S.L.
  • Haemostatix Ltd
  • QRxPharma Limited
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Hemorrhage Overview

Therapeutics Development

Pipeline Products for Hemorrhage - Overview

Pipeline Products for Hemorrhage - Comparative Analysis

Hemorrhage - Therapeutics under Development by Companies

Hemorrhage - Therapeutics under Investigation by Universities/Institutes

Hemorrhage - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Hemorrhage - Products under Development by Companies

Hemorrhage - Products under Investigation by Universities/Institutes

Hemorrhage - Companies Involved in Therapeutics Development

Cellphire, Inc.

Digna Biotech, S.L.

Haemostatix Ltd

QRxPharma Limited

Serendex Pharmaceuticals A/S

Thrombotargets Corporation

Hemorrhage - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

DB-055 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

eptacog alfa - Drug Profile

Product Description

Mechanism of Action

R&D Progress

PeproStat - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Protein for Hematological Disorders, Dermatology, Shock and Injury - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Q-8008 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Thrombosomes - Drug Profile

Product Description

Mechanism of Action

R&D Progress

TT-111 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

TT-112 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

V-0801 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Hemorrhage - Recent Pipeline Updates

Hemorrhage - Dormant Projects

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Hemorrhage, H1 2015

Number of Products under Development for Hemorrhage - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Number of Products under Investigation by Universities/Institutes, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Development, H1 2015

Products under Development by Companies, H1 2015

Products under Investigation by Universities/Institutes, H1 2015

Hemorrhage - Pipeline by Cellphire, Inc., H1 2015

Hemorrhage - Pipeline by Digna Biotech, S.L., H1 2015

Hemorrhage - Pipeline by Haemostatix Ltd, H1 2015

Hemorrhage - Pipeline by QRxPharma Limited, H1 2015

Hemorrhage - Pipeline by Serendex Pharmaceuticals A/S, H1 2015

Hemorrhage - Pipeline by Thrombotargets Corporation, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Stage and Target, H1 2015

Number of Products by Stage and Mechanism of Action, H1 2015

Number of Products by Stage and Route of Administration, H1 2015

Number of Products by Stage and Molecule Type, H1 2015

Hemorrhage Therapeutics - Recent Pipeline Updates, H1 2015

Hemorrhage - Dormant Projects, H1 2015

List of Figures

Number of Products under Development for Hemorrhage, H1 2015

Number of Products under Development for Hemorrhage - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Products, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Top 10 Targets, H1 2015

Number of Products by Stage and Top 10 Targets, H1 2015

Number of Products by Top 10 Routes of Administration, H1 2015

Number of Products by Stage and Top 10 Routes of Administration, H1 2015

Number of Products by Top 10 Molecule Types, H1 2015

Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Cellphire, Inc.
Digna Biotech, S.L.
Haemostatix Ltd
QRxPharma Limited
Serendex Pharmaceuticals A/S
Thrombotargets Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.